Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Docosahexaenoic acid (DHA, C22:6) is highly enriched in brain, synapses, and retina and is a major omega-3 fatty acid. Deficiencies in this essential fatty acid are reportedly associated with neuronal function, cancer, and inflammation. Here, using new lipidomic analyses employing high performance liquid chromatography coupled with a photodiode-array detector and a tandem mass spectrometer, a novel series of endogenous mediators was identified in blood, leukocytes, brain, and glial cells as 17S-hydroxy-containing docosanoids denoted as docosatrienes (the main bioactive member of the series was 10,17S-docosatriene) and 17S series resolvins. These novel mediators were biosynthesized via epoxide-containing intermediates and proved potent (pico- to nanomolar range) regulators of both leukocytes reducing infiltration in vivo and glial cells blocking their cytokine production. These results indicate that DHA is the precursor to potent protective mediators generated via enzymatic oxygenations to novel docosatrienes and 17S series resolvins that each regulate events of interest in inflammation and resolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![FIG. 3 Human glial cells release and transform DHA. A , human glial cells were labeled with [1- 14 C]DHA and exposed to either PBS alone, zymosan A, or calcium ionophore (see 'Experimental Procedures'). Released [114 C]docosanoids were quantified ( n = 4). The asterisk denotes significant differences from control (PBS alone), p < 0.05 analysis of variance, Newman-Keuls test. The inset shows a representative HPLC radiochromatogram of released [1- 14 C]docosanoids (see 'Experimental Procedures') from glial cells exposed to zymosan A ( n = 3). Phospholipids from glial cells were identified, and the 14 C content in phosphatidylethanolamine ( PE ) was determined. The percent loss in PE 14 C content from cells exposed to agonists was determined ( n = 2). B , lipidomic profile of human glial cells exposed to Ca 2 + ionophore: LC-MS total ion chromatogram of released products. C , LC-MS selective ion chromatogram of released DHA-derived products from glial cells exposed to calcium ionophore. MS-MS and UV spectra of 𝛚 -22hydroxy-4 S ,17 S -diHDHA.](https://figures.cochat.ai/paper-figures/3022e35eb41542a6a28d8ac7db63b15b/novel-docosatrienes-and-17s-resolvins-generated-from-docosahexaenoic-acid-in-figure-3.png)



![FIG. 5 Substrate competition at human recombinant COX-2. Human rCOX-2 microsomal membranes from Sf9 cells were incubated with [1- 14 C]DHA (C22:6, 10 𝛍 M) in the presence of increasing concentrations of unlabeled arachidonic acid (C20:4). COX-2 conversion of [1- 14 C]DHA and specific product profiles were quantitated ( n = 3). rCOX-2 activity is expressed as the inhibition of [ 14 C]C22:6 product formation (95 ± 0.5%; conversion of DHA was set to 100%).](https://figures.cochat.ai/paper-figures/b879709650c441a69692ab58e3270712/novel-docosatrienes-and-17s-resolvins-generated-from-docosahexaenoic-acid-in-figure-5.png)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prostaglandin E2 (PGE2) and D2 rapidly initiate the resolution process by inducing the expression of lipid mediators with both anti-inflammatory and pre-resolution functions, e.g., lipoxins [96, 97], resolvins and protectins [98–100], a process known as lipid-mediator class switch [97].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [98]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Self-citationSerhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Self-citationMarchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189
Self-citationA NEW DEFICIENCY DISEASE PRODUCED BY THE RIGID EXCLUSION OF FAT FROM THE DIET
Burr, G. O., & Burr, M. M. (1929) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)78281-5 · Cited by 1,185
Gunstone, F. D., Harwood, J. L., & Padley, F. B. (1994) · Cited by 1,010
Mechanisms of action of docosahexaenoic acid in the nervous system
Salem, N., Litman, B., Kim, H., & Gawrisch, K. (2001) · Lipids · doi:10.1007/s11745-001-0805-6 · Cited by 919
Fish consumption and major depression
Hibbeln, J. R. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79168-6 · Cited by 896
Research works printed but not linked: 8
- Gallin, J. I., and Snyderman, R. (eds) (1999) Inflammation: Basic Principles and Clinical Correlates, Lippincott Williams & Wilkins, Philadelphia
- Bergstro ¨m, S. (1982) in Les Prix Nobel: Nobel Prizes, Presentations, Biogra- phies and Lectures, pp. 129 -148, Almqvist & Wiksell, Stockholm
- De Caterina, R., Endres, S., Kristensen, S. D., and Schmidt, E. B. (eds) (1993) n-3 Fatty Acids and Vascular Disease, Springer-Verlag, London
- Gronert, K., Clish, C. B., Romano, M., and Serhan, C. N. (1999) in Eicosanoid Protocols (Lianos, E. A., ed) pp. 119 -144, Humana Press, Totowa, NJ 28.
- Gronert, K., Colgan, S. P., and Serhan, C. N. (1998) J. Pharmacol. Exp. Ther. 285, 252-261
- Whelan, J., Reddanna, P., Nikolaev, V., Hildenbrandt, G. R., and Reddy, T. S. (1990) in Biological Oxidation Systems Vol. 2, pp. 765-778, Academic Press
- Bazan, N. G. (1990) in Nutrition and the Brain (Wurtman, R. J., and Wurtman, J. J., eds) Vol. 8, pp. 1-22, Raven Press, New York
- Bazan, N. G., and Rodriguez de Turco, E. B. (2001) in Neuroprotection (Lo, E. H., and Marwoh, J., eds) pp. 195, Prominent Press
Cited by
Items 701–800 of 997
Specialized pro-resolving lipid mediators and resolution of viral diseases
Ferri, G., Mucci, M., Mattoscio, D., & Recchiuti, A. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106762 · Cited by 13
Zia, B., Elmeky, M., Azimullah, S., Jha, N. K., Meeran, M. F. N., & Ojha, S. K. (2025) · Current Neuropharmacology · doi:10.2174/011570159x365720250225080257 · Cited by 14
Jouvene, C. C., Fourmaux, B., Géloën, A., Balas, L., Durand, T., Lagarde, M., Létisse, M., & Guichardant, M. (2018) · Lipids · doi:10.1002/lipd.12006 · Cited by 13
Acar, N., Parlak, H., Özkan, A., Soylu, H., Avcı, S., Üstünel, İ., Izgut-Uysal, V. N., & Ağar, A. (2018) · Tissue and Cell · doi:10.1016/j.tice.2018.12.002 · Cited by 14
Yang, M., Bair, J. A., Hodges, R. R., Serhan, C. N., & Dartt, D. A. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.06.001 · Cited by 13
Self-citationJin, J., Boeglin, W. E., & BRASH, A. R. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100088 · Cited by 15
“(44) as docosatrienes, which seems apt and well put.”
BackgroundRodríguez‐Santana, Y., Ochoa, J. J., Lara‐Villoslada, F., Kajarabille, N., Saavedra, P., Hurtado, J. A., Peña‐Caballero, M., Díaz‐Castro, J., Sebastian-Garcia, I., Machin-Martin, E., et al. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.09.006 · Cited by 17
“Additionally, it promotes the production of lipid mediators [19] with anti-inflammatory [20-22] and immuno modulatory effects [18].”
BackgroundNew Lipid Mediators in Retinal Angiogenesis and Retinopathy
Fleming, I. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00739 · Cited by 15
“…included in targeted mass spectrometry-based screens, possible examples being 17S-hydroxy-containing docosanoids and 17S series resolvins that are reportedly biosynthesized via epoxidecontaining intermediates in murine brain, human blood, and glial cells (Hong et al., 2003; Hu et al., 2017b).”
BackgroundSinclair, A. J., & Jayasooriya, A. P. (2010) · Elsevier eBooks · doi:10.1016/b978-1-893997-73-8.50020-7 · Cited by 13
Lipidomics in triacylglycerol and cholesteryl ester oxidation
Kuksis, A. (2007) · Frontiers in bioscience · doi:10.2741/2307 · Cited by 13
Thomas, C. P., Tyrrell, V. J., Burston, J. J., Johnson, S. R. C., Aldrovandi, M., Álvarez-Jarreta, J., Inglis, R., Leonard, A., Fice, L., Costales, J., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2502640122 · Cited by 17
Effect of diet with omega-3 in basal brain electrical activity and during status epilepticus in rats
Pessoa, D. T., da Silva, E. L. A., Costa, E. V. L., & Nogueira, R. A. (2017) · Epilepsy Research · doi:10.1016/j.eplepsyres.2017.08.014 · Cited by 12
Hamidzadeh, K., Westcott, J., Wourms, N., Shay, A. E., Panigrahy, A., Martin, M. J., Nshimiyimana, R., & Serhan, C. N. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115181 · Cited by 13
Self-citationMolecular Circuits of Resolution in Airway Inflammation
Carlo, T., & Levy, B. D. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.143 · Cited by 14
Pathways involved in the resolution of inflammatory joint disease
Haworth, O., & Buckley, C. D. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.04.002 · Cited by 13
Homann, J., Suo, J., Schmidt, M., de Bruin, N. M. W. J., Scholich, K., Geißlinger, G., & Ferreirós, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143141 · Cited by 13
Caron, J. P., Gandy, J. C., Brown, J. L., & Sordillo, L. M. (2018) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2018.05.006 · Cited by 14
Oxygenated lipid signaling in tumor-associated macrophages—focus on colon cancer
Colby, J. K., Jaoude, J. C., Liu, F., & Shureiqi, I. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9743-z · Cited by 13
Khaddaj‐Mallat, R., Sirois, C., Sirois, M., Rizcallah, E., Morin, C., & Rousseau, É. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.04.005 · Cited by 15
Lagarde, M. (2010) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201000045 · Cited by 12
Specialized pro‐resolving mediators: wiring the circuitry of effector immune and tissue homeostasis
Fredman, G., & Serhan, C. N. (2011) · Endodontic Topics · doi:10.1111/etp.12010 · Cited by 13
Self-citationGaertner, S., Auger, C., Farooq, M. A., Pollet, B., Khemais‐Benkhiat, S., Niazi, Z. R., Schrevens, S., Park, S., Toti, F., Stéphan, D., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030920 · Cited by 14
Lipid Mediator Informatics-Lipidomics: Novel Pathways in Mapping Resolution
Serhan, C. N., Hong, S., & Lu, Y. (2006) · The AAPS Journal · doi:10.1208/aapsj080233 · Cited by 12
Self-citationLipids in the Treatment of Neurodegenerative Diseases
Lange, K. W. (2020) · Wiley eBooks · doi:10.1002/047167849x.bio118 · Cited by 12
The biosynthetic pathways of the protectins
Haatveit, Å. S., & Hansen, T. V. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106787 · Cited by 12
Tawfik, B., Dayao, Z. R., Brown-Glaberman, U. A., Pankratz, V. S., Lafky, J. M., Loprinzi, C. L., & Barton, D. L. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-08082-x · Cited by 11
Lipoxins, resolvins and protectins: new leads for the treatment of asthma
Haworth, O., & Levy, B. D. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.10.1209 · Cited by 12
Masoodi, M., & Volmer, D. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1258-2_14 · Cited by 11
Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults
Terrando, N., Park, J. J., Devinney, M. J., Chan, C. C. W., Cooter, M. L., Avasarala, P., Mathew, J. P., Quiñones, Q. J., Maddipati, K. R., Berger, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82606-5 · Cited by 11
Rincón‐Cervera, M. Á., Bravo, R., Freitas, R. A. M. S., López‐Arana, S., & de Camargo, A. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823569-0.00005-9 · Cited by 17
Reinertsen, A. F., Libreros, S., Nshimiyimana, R., Serhan, C. N., & Hansen, T. V. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00201 · Cited by 13
Self-citationImplications of dietary fat for nutrition and energy balance
Wenk, C. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.07.025 · Cited by 12
Rosenberger, T. A., Villacreses, N. E., Weis, M. T., & Rapoport, S. I. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.12.010 · Cited by 13
“Eicosanoids, cyclooxygenase and lipoxygenase products are considered pro-inflammatory (Shimizu and Wolfe, 1990; Flower et al., 1972) while docosanoids, lipoxygenase products, are considered anti-inflammatory (Marcheselli et al., 2003; Hong et al., 2003; Serhan et al., 2002).”
Wang, T., Gao, Z., Ru, X., Wang, X., Yang, B. H., & Zhang, L. (2023) · Marine Environmental Research · doi:10.1016/j.marenvres.2023.105944 · Cited by 10
Lu, Y., Tian, H., Peng, H., Wang, Q., Bunnell, B. A., Bazan, N. G., & Hong, S. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1380059 · Cited by 10
Self-citationBrain fatty acid and transcriptome profiles of pig fed diets with different levels of soybean oil
da Silva, B. P. M., Fanalli, S. L., Gomes, J. D., de Almeida, V. V., Fukumasu, H., Freitas, F. A. O., Moreira, G. C. M., Silva‐Vignato, B., Reecy, J. M., Koltes, J. E., et al. (2023) · BMC Genomics · doi:10.1186/s12864-023-09188-6 · Cited by 17
“Another important mediator related to the resolution of inflammation, reduction of leukocyte trafficking, and negative regulation of cytokine expression is neuroprotectin D1 (NPD1) [41, 42].”
BackgroundCaputo, M. P., Radlowski, E. C., Lawson, M. A., Antonson, A. M., Watson, J. E., Matt, S. M., Leyshon, B. J., Das, A., & Johnson, R. W. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.046 · Cited by 10
Local shifts in inflammatory and resolving lipid mediators in response to tendon overuse
Markworth, J. F., Sugg, K. B., Sarver, D. C., Maddipati, K. R., & Brooks, S. V. (2021) · The FASEB Journal · doi:10.1096/fj.202100078r · Cited by 14
Is Alzheimer's Disease a Synaptic Disorder?
Pomponi, M., Bria, P., & Pomponi, M. F. L. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13104 · Cited by 11
Sinclair, A. J., Attar‐Bashi, N. M., Jayasooriya, A. P., Gibson, R. A., & Makrides, M. (2005) · RMIT Research Repository (RMIT University Library) · Cited by 10
Interface between Resolvins and Efferocytosis in Health and Disease
Mohammad‐Rafiei, F., Negahdari, S., Tahershamsi, Z., & Hayat, S. M. G. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01187-4 · Cited by 9
“The production of 17 R resolvins or aspirin-triggered RvD (AT-RvD) occurs due to the conversion of DHA to 17R-hydroperoxy intermediate by acetylated COX-2 and the production of 17S-series resolvins (RvD1 – 6) occurs due to the conversion of DHA [49, 75].”
Pinosylvin exacerbates LPS-induced apoptosis via ALOX 15 upregulation in leukocytes
Kwon, O., Seo, Y., & Park, H. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.6.024 · Cited by 9
“Prostaglandins E2 and D2 then stimulate transcriptional activity of lipoxins, resolvins, and protectins, the dominant activators for inflammation resolution (20, 22-24).”
BackgroundResolvin D1 Administration Is Beneficial in Trypanosoma cruzi Infection
Horta, A. L., Williams, T. M., Han, B., Ma, Y., Menezes, A. P. D. J., Tu, V., Talvani, A., Weiss, L. M., & Huang, H. (2020) · Infection and Immunity · doi:10.1128/iai.00052-20 · Cited by 11
“RvD1 (7S,8R,17S-trihydroxy-4Z,9E,11E,13Z,15E,19Zdocosahexaenoic acid) (26) is produced in vivo through docosahexaenoic acid (DHA) by the enzymatic activity of 15-lipoxygenase (15-LO) and 5-LO (27, 28).”
BackgroundReinertsen, A. F., Primdahl, K. G., Matteis, R. D., Dalli, J., & Hansen, T. V. (2021) · Chemistry - A European Journal · doi:10.1002/chem.202103857 · Cited by 9
Chemical Mediators and the Resolution of Airway Inflammation
Carlo, T., & Levy, B. D. (2008) · Allergology International · doi:10.2332/allergolint.08-rai-0018 · Cited by 12
Stereocontrolled synthesis of resolvin D1
Morita, M., Wu, S., & Kobayashi, Y. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob03128b · Cited by 9
Zhang, C. (2013) · HARVEST (University of Saskatchewan) · Cited by 9
Understanding the Role of Polyunsaturated Fatty Acids in the Development and Prevention of Cancer
Akbar, S., Rahman, A., Aḥmad, N., Imran, M., & Hafeez, Z. (2024) · Cancer treatment and research · doi:10.1007/978-3-031-55622-7_3 · Cited by 193
Wenderoth, T., Feldotto, M., Hernandez, J., Schäffer, J., Leisengang, S., Pflieger, F. J., Bredehöft, J., Mayer, K., Kang, J. X., Bier, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189904 · Cited by 11
“We focused on the substrates derived from AA, DHA, and EPA, namely leukotriene (LT)B4, 18-HEPE, RvE1, 18-oxo-RvE1, 14(S)-HDHA, 17(S)-HDHA, RvD1, and RvD2, as these have been shown to be of particularly high relevance for the resolution of inflammation [21,27,28,60].”
BackgroundHachem, M. (2021) · Biochimie · doi:10.1016/j.biochi.2021.02.012 · Cited by 8
Perry, S., van Hoorebeke, C., Sorrentino, J. T., Bautista, L., Akinkugbe, O., Conrad, W. S., Rutz, N., & Holman, T. R. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109317 · Cited by 9
Jackson, C. D., Hilliard, K. A., & Brown, C. R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1144172 · Cited by 9
“As COX-2 products, 5-LO, and 12/15LO can cooperate in lipoxin and SPM synthesis (8, 15, 16), the nonresolution phenotype seen in COX-2, 5-LO, and 12/15LO mice despite spirochete clearance from the joint may be due to a shared defect of lipoxin and SPM production.”
BackgroundWang, K., Zhang, Y., Shu, R., Yuan, L., Tu, H., Wang, S., Ni, B., Zhang, Y., Jiang, C., Luo, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202417367 · Cited by 8
Essential Fatty Acids—Biochemistry, Physiology and Clinical Significance
Das, U. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0495-4_4 · Cited by 12
Calderon Artero, P. (2011) · Journal of Glycomics & Lipidomics · doi:10.4172/2153-0637.1000104 · Cited by 8
Primdahl, K. G., Stenstrøm, Y., Hansen, T. V., & Vik, A. (2016) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2015.12.005 · Cited by 8
Serum Resolvin E1 Levels and Its Relationship with Disease Activity in Ulcerative Colitis
Günay, S., Taşova, F., Yılmaz, H. E., Paköz, Z. B., & Çekiç, C. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/6258327 · Cited by 8
Caplan, M. S. (2007) · ePrints Soton (University of Southampton) · Cited by 8
Major Structure–Activity Relationships of Resolvins, Protectins, Maresins and Their Analogues
Daly, K., O'Sullivan, K., & O’Sullivan, T. P. (2022) · Future Medicinal Chemistry · doi:10.4155/fmc-2022-0206 · Cited by 8
Hadley, K. B., Ryan, A. S., Nelson, E. B., & Salem, N. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2010.07.006 · Cited by 8
Neutrophil unsaturated fatty acid release by GM-CSF is impaired in cystic fibrosis
Bravo, E., Napolitano, M., Valentini, S. B., & Quattrucci, S. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-129 · Cited by 8
“As the discovery of these molecules is relatively recent and the direct analyses of these compounds requires Liquid Chromatography with Tandem Mass Spectrometry Detection [3], most of the available studies have been focused the regulation of AA cascade, while the modulation of DHA metabolism has been poorly investigat…”
BackgroundAlkazemi, D. U. Z., Jackson, R. L., Chan, H. M., & Kubow, S. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4096 · Cited by 8
“with reduced cardiovascular risk and mortality (1, 2).”
BackgroundZhang, Y., & Igwe, O. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.021 · Cited by 8
Roberts, C. K. (2014) · CRC Press eBooks · doi:10.1201/b16783-5 · Cited by 8
Xu, B., Yuan, H., Li, X., Yu, Q., Dai, C., & Dong, Z. (2024) · Pediatric Discovery · doi:10.1002/pdi3.91 · Cited by 7
Polyunsaturated Fatty Acids and Inflammation: Therapeutic Potential in Rheumatoid Arthritis
Calder, P. C. (2009) · Current Rheumatology Reviews · doi:10.2174/157339709790192558 · Cited by 11
Roles of Docosahexaenoic and Eicosapentaenoic Acids in Brain
Farooqui, A. A. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0543-7_5 · Cited by 8
Albumin Infusion Therapy in Stroke, Sepsis and the Critically Ill
Das, U. N. (2008) · Current Nutrition & Food Science · doi:10.2174/157340108785133329 · Cited by 7
“Of the several 17-hydroxy-containing bioactive mediators derived from DHA that were termed docosatrienes and 17S series resolvins, 10,17S-dihydroxydocosatriene is termed as neuroprotectin D1 (NPD1) that reduced infiltration of PMNs, showed anti-inflammatory and neuroprotective properties [60, 61].”
BackgroundPlant Metabolites Involved in Plant–Pathogen Interactions
Parween, D., Sahu, B. B., Kumari, M., & Pudake, R. N. (2019) · Springer eBooks · doi:10.1007/978-3-030-26657-8_5 · Cited by 9
de Souza, W. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80373 · Cited by 10
Enzymatic studies with 3-oxa n-3 DPA
Pangopoulos, M. K., Nolsøe, J. M. J., Antonsen, S. G., Colas, R. A., Dalli, J., Aursnes, M., Stenstrøm, Y., & Hansen, T. V. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103653 · Cited by 7
Role of omega-3 polyunsaturated fatty acids in diet of patients with rheumatic diseases
Sales, C., Oliviero, F., & Spinella, P. (2011) · Reumatismo · doi:10.4081/reumatismo.2008.95 · Cited by 13
“Dal DHA originano invece le resolvine D, aventi azione antinfiammatoria simile alle risolvine E, e le protectine aventi azione immunoregolatrice e benefica nei confronti di vari tessuti dell’organismo in particolare quelli del sistema nervoso (23, 24).”
BackgroundPilkington, S. M., & Rhodes, L. E. (2010) · Springer eBooks · doi:10.1007/978-3-642-12264-4_9 · Cited by 9
Dietary Fatty Acids and Eicosanoids
Lee, J., & Hwang, D. H. (2007) · Food science and technology · doi:10.1201/9781420006902.ch28 · Cited by 8
Antiinflammatory effects of ω-3 fatty acids vary at different stages of inflammation
Nohé, B., Johannes, T., & Dieterich, H. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01138.2002 · Cited by 7
dos Santos, H. T., Nam, K., Gil, D., Yellepeddi, V., & Baker, O. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1094278 · Cited by 7
ALX/FPR2 Activation by Stereoisomers of D1 Resolvins Elucidating with Molecular Dynamics Simulation
Nunes, V. S., Abrahão, O., Rogério, A. D. P., & Serhan, C. N. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c01787 · Cited by 11
Self-citationEbrahimi, E., Motamedi-Tehrani, J., & Peyghan, R. (2025) · Aquaculture Nutrition · doi:10.1155/anu/8840365 · Cited by 6
Fatty acid metabolism in the placentae of gestational diabetes mellitus
Joshi, N. P., & Joshi, S. (2025) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2025.102682 · Cited by 6
Feng, G., Chen, J.-H., Lin, C., & Yang, J.-M. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0278-0 · Cited by 6
Frost, B. L., & Caplan, M. S. (2018) · Clinics in Perinatology · doi:10.1016/j.clp.2018.09.004 · Cited by 6
Evaluation of Cancer Cell Growth Suppressibility of ω-3 Fatty Acids and Their Metabolites
Tojo, T., Tsuruoka, M., Kondo, T., & Yuasa, M. (2022) · Journal of Oleo Science · doi:10.5650/jos.ess22183 · Cited by 6
Resolvins, protectins and other lipid mediators in obesity-associated inflammatory disorders
Clària, J., Titos, E., López‐Vicario, C., & González‐Périz, A. (2010) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2010.10.002 · Cited by 10
Rueda, F., Domingo, J. C., & Mach, N. (2011) · Revista Española de Nutrición Humana y Dietética · doi:10.1016/s2173-1292(11)70004-7 · Cited by 13
Hansen, T. V., Dalli, J., & Serhan, C. N. (2016) · RSC Advances · doi:10.1039/c6ra00414h · Cited by 7
Self-citationThe Role of Chondroprotectants, Nutraceuticals, and Nutrition in Rehabilitation
Raditic, D., & Bartges, J. W. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-0309-2.00015-6 · Cited by 6
Prevention of Oxidative Stress by Omega-3 Fatty Acids in the Brain
Farooqui, A. A., & Farooqui, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-40458-5_19 · Cited by 8
Bao, Q., Liu, Y., Song, H., Yang, N., Ai, D., Zhu, Y., & Zhang, X. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12825 · Cited by 6
Antiaging and Neuroprotective Properties of Mediterranean Diet Components in Humans
Farooqui, A. A., & Farooqui, T. (2018) · Springer eBooks · doi:10.1007/978-981-13-1699-9_15 · Cited by 7
Understanding the Role of Pro-resolving Lipid Mediators in Infectious Keratitis
Berger, E. A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21735-8_2 · Cited by 7
Ganea, D., Kocieda, V., Kong, W., & Yen, J.-H. J. (2011) · Clinical Lipidology · doi:10.2217/clp.11.12 · Cited by 6
Die Rolle neuer „pro-resolving” Lipidmediatoren bei entzündlichen Lungenerkrankungen
Eickmeier, O., Hilberath, J. N., Zielen, S., & Haworth, O. (2010) · Pneumologie · doi:10.1055/s-0030-1255913 · Cited by 8
Lipoxins and Aspirin-Triggered 15-epi-Lipoxins
Serhan, C. N. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00152-2 · Cited by 6
Self-citationFirst total synthesis of the anti-inflammatory and pro-resolving lipid mediator 16(R),17(S)-diHDHA
Rodrı́guez, A. R., & Spur, B. W. (2018) · Tetrahedron Letters · doi:10.1016/j.tetlet.2018.02.029 · Cited by 6
Wildburger, N. C., Lichti, C. F., LeDuc, R. D., Schmidt, M. E., Kroes, R. A., Moskal, J. R., & Nilsson, C. L. (2015) · EuPA Open Proteomics · doi:10.1016/j.euprot.2015.06.006 · Cited by 6
Ramadan, E., Basselin, M., Chang, L., Chen, M., Ma, K., & Rapoport, S. I. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9381-0 · Cited by 5
“Moreover, in the same rat model, chronic lithium feeding increased brain levels of 17-hydroxydocosahexaenoic acid, which is a precursor of anti-inflammatory resolvins and neuroprotectins (Basselin et al. 2010; Hong et al. 2003).”
Eicosanoids Signals in SARS-CoV-2 Infection: A Foe or Friend
Rahman, M. S., & Hossain, M. S. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00919-4 · Cited by 5
Resolution and Regulation of Inflammation
Levy, B. D., & Serhan, C. N. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.01811-6 · Cited by 8
Self-citationDobson, E. P., Barrow, C. J., & Adcock, J. L. (2014) · Journal of Molecular Catalysis B Enzymatic · doi:10.1016/j.molcatb.2014.07.007 · Cited by 5
Proresolving mediators: new therapies to treat inflammatory diseases
Stopka‐Farooqui, U., & Haworth, O. (2015) · Clinical Lipidology · doi:10.2217/clp.15.19 · Cited by 6
Metadata
- Authors
- Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Serhan, Charles N.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-04
- Volume
- 278
- Issue
- 17
- Pages
- 14677-14687
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2082649626
- Cited by
- 1,000
- References
- 53
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 24 · 2023: 32 · 2022: 24 · 2021: 42 · 2020: 36 · 2019: 51 · 2018: 44 · 2017: 43 · 2016: 40 · 2015: 59 · 2014: 66 · 2013: 63 · 2012: 48
- FWCI
- 34.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6388 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institute of General Medical Sciences (GM 38765)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK60583, K01DK060583)
- National Institute of Dental and Craniofacial Research (P01 DE 13499, P01DE013499)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- docosahexaenoic acid, docosanoids, omega-3 fatty acids, leukocyte infiltration, glial cells, cytokine production, inflammation resolution, epoxide intermediate, lipidomics, brain, leukocytes, leukotriene biosynthesis
- MeSH terms
- Animals, Blood, Brain, Chemotaxis, Leukocyte, Chromatography, High Pressure Liquid, Docosahexaenoic Acids, Fatty Acids, Unsaturated, Humans, Inflammation, Leukocytes, Neuroglia, Mass Spectrometry, Tumor Necrosis Factor-alpha, Cytokines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.